The aims of this study were to isolate sesquiterpene compounds from the largehead atractylodes rhizome (LAR) and to investigate their effects on B16 cancer cells. A total of 8 sesquiterpenes from LAR were identified, of which eudesm-4 (15), 7-diene-9α, 11-diol (7) was isolated for the first time. All 8 compounds inhibited growth of B16 cells, and atractylenolide I (AT-I), atractylenolide II (AT-II), and atractylenolactam (ATR) were the most potent, with IC50 values of 76.46, 84.02, and 54.88 μΜ, respectively. Monomer lactone or lactam structures in the 8 compounds appeared to be critical for their antiproliferative activities. In addition, AT-I, AT-II, and ATR could induce cell differentiation and inhibit cell migration. Western blot analysis indicated that 2 of the compounds, AT-I and AT-II, could inactivate ERK, where all 3 inhibited AKT activation, suggesting that Ras/ERK and PI3K/AKT signaling pathways are involved in the action mechanisms of the LAR sesquiterpene compounds.
Huang BS, Sun JS, Chen ZLIsolation and identification of atractylenolide VI from Atractylodes macrocephala Koidz. Acta Bot Sin. 1992;34:614-617.
5.
Li CQ, He LC, Dong HY, Jin JQScreening for the antiinflammatory activity of fractions and compounds from Atractylodes macrocephala koidz. J Ethnopharmacol. 2007;114: 212-217.
6.
Li CQ, He LC, Jin JQAtractylenolide I and atractylenolide III inhibit lipopolysaccharide-induced TNF-alpha and NO production in macrophages. Phytother Res . 2007;21:347-353.
7.
Matsuda H., Li YH, Taniguchi K., Yamahara J., Tamai Y.Imaging analysis of antiulcer action and the active constituent of Atractylodis rhizoma. Yakugaku Zasshi. 1991;111:36-39.
8.
Nogami M., Iwanaga M., Moriura T., Kubo M.Studies on the origin, processing and quality of crude drugs. V. Pharmacologic evaluations of the Chinese drug "zhu" in experimental gastric ulcer. (5). The preventive effects of Atractylodes ovata on stress-induced gastric ulcer [in Japanese]. Yakugaku Zasshi. 1986;106:498-503.
9.
Kubo M., Nogami M., Nishimura M., Moriura T., Arichi S.Origins, processing, and qualities of crude drugs (1). Preventive effects of a Chinese crude drug, Zhu, on experimental stomach ulcer and its pharmacological evaluation 1 [in Japanese]. Yakugaku Zasshi. 1983;103:442-448.
10.
Kiso Y., Tohkin M., Hikino H.Mechanism of antihepatotoxic activity of atractylon, I: Effect on free radical generation and lipid peroxidation. Planta Med. 1985;(2):97-100.
11.
Mori H., Xu Q., Sakamoto O., Uesugi Y., Koda A., Nishioka I.Mechanisms of antitumor activity of aqueous extracts from Chinese herbs: their immunopharmacological properties. Jpn J Pharmacol. 1989;49:423-431.
12.
Kimura I.Medical benefits of using natural compounds and their derivatives having multiple pharmacological actions. Yakugaku Zasshi. 2006;126:133-143.
13.
Tsuneki H., Ma EL, Kobayashi S., et al. Antiangiogenic activity of beta-eudesmol in vitro and in vivo . Eur J Pharmacol. 2005;512:105-115.
14.
Wang CC, Lin SY, Cheng HC, Hou WCPro-oxidant and cytotoxic activities of atractylenolide I in human promyeloleukemic HL-60 cells. Food Chem Toxicol. 2006;44:1308-1315.
15.
Wang CC, Chen LG, Yang LLCytotoxic activity of sesquiterpenoids from Atractylodes ovata on leukemia cell lines. Planta Med. 2002;68:204-208.
16.
Wang HZ, Zhang Y., Xie LP, Yu XY, Zhang RQEffects of genistein and daidzein on the cell growth, cell cycle, and differentiation of human and murine melanoma cells. J Nutr Biochem. 2002;13:421-426.
17.
Liu Y., Jia Z., Dong L., Wang R., Qiu G.A randomized pilot study of atractylenolide I on gastric cancer cachexia patients . Evid Based Complement Alternat Med. 2008 ;5:337-344.
18.
Liu Y., Ye F., Qiu GQ, et al. Effects of lactone I from Atractylodes macrocephala Koidz on cytokines and proteolysis-inducing factors in cachectic cancer patients. Di Yi Jun Yi Da Xue Xue Bao. 2005;25:1308-1311.
19.
Hoang MT, Eichenfield LFThe rising incidence of melanoma in children and adolescents. Dermatol Nurs. 2000;12:188-189, 192-193.
20.
Legha SS, Ring S., Eton O., et al. Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma. J Clin Oncol. 1998;16: 1752-1759.
21.
Sun W., Schuchter LMMetastatic melanoma. Curr Treat Options Oncol. 2001;2:193-202.
22.
Ji LL, Zhang M., Sheng YC, Wang ZTPyrrolizidine alkaloid clivorine induces apoptosis in human normal liver L-02 cells and reduces the expression of p53 protein. Toxicol In Vitro. 2005;19:41-46.
23.
Ren KK, Wang HZ, Xie LP, et al. The effects of oridonin on cell growth, cell cycle, cell migration and differentiation in melanoma cells. J Ethnopharmacol. 2006;103:176-180.
24.
Hirata N., Naruto S., Ohguchi K., et al. Mechanism of the melanogenesis stimulation activity of (-)-cubebin in murine B16 melanoma cells. Bioorg Med Chem. 2007;15:4897-4902.
25.
Hintermann E., Bilban M., Sharabi A., Quaranta V.Inhibitory role of alpha 6 beta 4-associated erbB-2 and phosphoinositide 3-kinase in keratinocyte haptotactic migration dependent on alpha 3 beta 1 integrin. J Cell Biol. 2001;153:465-478.
26.
Freitas ZF, Rodrigues EG, Oliveira V., Carmona AK, Travassos LRMelanoma heterogeneity: differential, invasive, metastatic properties and profiles of cathepsin B, D and L activities in subclones of the B16F10-NEX2 cell line. Melanoma Res. 2004;14:333-344.
27.
Zhang XL, Lai GF, Xu YL, Luo SDStudy on the chemical constituents from Atractylodes macrocephala. Nat Prod Res Dev. 2008;20:5-7.
28.
Wang BD, Yu YH, Teng LLThe structural identification of the biepiasterolide. Acta Chim Sin. 1999;57:1022-1025.
29.
Wang HX, Liu CM, Liu Q., Gao K.Three types of sesquiterpenes from rhizomes of Atractylodes lancea. Phytochemistry. 2008;69:2088-2094.
30.
Zhao X., Wakamatsu Y., Shibahara M., et al. Mannosylerythritol lipid is a potent inducer of apoptosis and differentiation of mouse melanoma cells in culture. Cancer Res. 1999;59: 482-486.
31.
Niles RM, Makarski JSControl of melanogenesis in mouse melanoma cells of varying metastatic potential . J Natl Cancer Inst. 1978;61:523-526.
32.
Huang HL, Chen CC, Yeh CY, Huang RLReactive oxygen species mediation of baizhu-induced apoptosis in human leukemia cells. J Ethnopharmacol. 2005;97:21-29.
33.
Sporn MB, Roberts ABRole of retinoids in differentiation and carcinogenesis. Cancer Res. 1983;43:3034-3040.
34.
Lee YN, Lee HY, Chung HY, et al. In vitro induction of differentiation by ginsenoides in F9 teratocarcinoma cells. Eur J Cancer. 1996;32A:1420-1428.
35.
Ridley AJ, Schwartz MA, Burridge K., et al. Cell migration: integrating signals from front to back. Science. 2003;302: 1704-1709.
36.
Russo AE, Torrisi E., Bevelacqua Y., et al. Melanoma: molecular pathogenesis and emerging target therapies (review). Int J Oncol. 2009;34:1481-1489.
37.
Molhoek KR, Brautigan DL, Slingluff CL Jr.Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin. J Transl Med. 2005;3:39.
